Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q1 2024 (March 31)3holders
$5.44avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings. The largest holders were Rhumbline Advisers ($83K), GAMMA Investing LLC ($37K) and PNC Financial Services Group, Inc. ($397).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $1K |
Ownership 3 holders
| Rhumbline Advisers | 0.00% | Add +18.1% | 15,275 | $83K |
| GAMMA Investing LLC | 0.01% | Add +932.3% | 6,710 | $37K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -22.3% | 73 | $397 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.